...Done!
Skip to main content
🔍 See what insiders are buying — free 7-day trial, no credit card required. Get started →
SYK NYSE 🇺🇸 US
Stryker Corp.
Healthcare
Watch
Price Zone: Buy Zone
🔒 Full AI Analysis — Pro
48Score
DipBuster Score™
$307.08 +$9.48 (+3.19%) Live price · Source: Yahoo
52-Week Position
$267.00 33% of range $389.33
Dividend
—
no income
Mkt Cap
N/A
total value
Mkt CapN/A
P/EN/A
DividendNone
BetaN/A
52W High$389.33
52W Low$267.00
DipBuster Brief Key signals at a glance
Zone: Buy Zone
Neutral
Mid-Range Position (33% of 52-Week Range)
The stock sits in the middle of its annual range — no extreme dip opportunity, but also not overextended.
Neutral
Earnings Data Unavailable
P/E ratio could not be determined — this is common for early-stage, loss-making, or recently-listed companies.
Valuation
P/E Ratio—
Mkt CapN/A
52W Position33% of range
EV/EBITDA—
Cash Flow
FCF Yield—
FCF / Share—
Op. Cash Flow—
Margins
Gross Margin—
Op. Margin—
Net Margin—
Balance Sheet
Cash—
Total Debt—
Net Cash—
Dividend
Yield—
Annual / shNone
Beta—
🔒 FCF, margins & balance sheet data are hidden — create a free account to see them.
Charts

Recent director dealings and insider transactions at Stryker Corp. (SYK), from SEC Form 4 filings. Open-market buys by directors spending their own money are one of the strongest signals in investing.

Date Insider Type Shares
2026-09-24 Wells Preston Wendell SELL 109
2026-09-22 Wells Preston Wendell SELL 962
2026-08-21 Crotty Dylan Bram SELL 441
2026-08-19 Stryker Ronda E SELL 805
2026-08-19 Stryker Ronda E SELL 3,852
2026-08-19 Stryker Ronda E SELL 3,274
2026-08-19 Stryker Ronda E SELL 16,612
2026-08-19 Stryker Ronda E SELL 10,812
2026-08-19 Stryker Ronda E SELL 11,257
2026-08-19 Stryker Ronda E SELL 2,308

Valuation

P/E RatioN/A
Market CapN/A
BetaN/A
Dividend/yrNone
52W High$389.33
52W Low$267.00

52-Week Range

$267.00Now$389.33
33% through annual range
From 52W High−21.1%
From 52W Low+15%
📖 Plain English Summary
Stryker Corp. is at 33% of its 52-week range.

🏦 Analyst Price Target

Loading…

🎯 Analyst Revenue & EPS Estimates

Loading estimates…

🔄 Peer Comparison

Loading peers…
Loading dividend data…
Latest news for SYK 🟢 Bullish ⬜ Neutral 🔴 Bearish
🤖
DipBuster AI Analysis — SYK
Heuristic · balance sheet, insider filings, price data, academic research

Stryker Corp. — DipBuster Score 48/100

Graham value assessment, NCAV analysis, price zones...

Insider signals, cluster detection, risk factors...

🔒
Full AI Analysis — Pro
Price zones, Graham analysis, insider signals
Upgrade →

Track Stryker Corp. free

Add SYK to a watchlist, set insider-buy and price alerts, and get the full financial picture — free account, no card.

Sponsored · FCA Regulated Broker
Hargreaves Lansdown
UK's #1 investment platform. ISA, SIPP, GIA. FCA regulated since 1981.
Open Account →
Capital at risk. Your investments can go down as well as up. Disclaimer
DipBuster Score™ Breakdown
Value & P/E 0/30
Dip Position 27/25
Momentum & Volume 16/25
Quality & Size 5/10
Insider Activity 0/10
🎯 Dip Buyer Signal
22 /100 · NEUTRAL
dip depth 22/25
oversold rsi 0/25
mean reversion 0/15
insider zone 0/25
capitulation 0/10
Technical signal only. Not financial advice.
Quick Take
🟡
Watch
DipBuster Score: 48/100
📈 Strong recent momentum — price and volume trending in the right direction.

More Healthcare stocks

UNH UnitedHealth GroupJNJ Johnson & JohnsonABT Abbott LaboratoriesTMO Thermo Fisher ScientificDHR Danaher Corp.MDT Medtronic plcBSX Boston ScientificEW Edwards LifesciencesAll Healthcare stocks →